A Study to Assess the Long-term Safety of QVA149

Clinical trial NCT01120717 · COMPLETED

Trial details

NCT number: NCT01120717
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2010-04-01
Primary completion: 2011-12-01
Enrollment: 339

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.